The Impact of COVID-19 Infection on Prognostic Effect of Liver Laboratory Markers and Disease Outcome
Severe acute respiratory syndrome-related coronavirus 2 (SARS- CoV-2) is a viral pathogen that causes coronavirus disease 2019 (COVID-19). Angiotensin-converting enzyme 2 (ACE2), as a receptor, is crucial for SARS-CoV-2 to get access into the host cells. According to reports, ACE2 is expressed in the liver, placenta, heart, lungs and kidneys. This study sought to gain unique insights into the features of liver indicators in individuals suffering from COVID-19 disease in order to enhance their therapeutic care. The study groups included 50 people diagnosed with COVID-19 infection in the patient’s group and 25 healthy people without any systemic diseases in the control group. Human serum samples were used to measure liver function enzymes, CRP, D dimer, and ferritin all samples by using automated quantitative tests. The results revealed a statically significant difference between AST, ALP, TSB, and study groups, where it is found that the mean levels of AST (88.04±33.00) and ALP (99.61±41.93) were high in patients than in controls, while the mean levels of TSB were low in patients (0.51±0.21) than the controls. A significant difference was also obtained for each ferritin, CRP, and D dimer between the study groups, where it found the mean concentrations of D dimer, ferritin and CRP, i.e., 1208.09±667.32, 60.53±23.91 and 204.52±90.62, respectively, were high in the patient’s group than in controls.
Bangash, M.N., Patel, J. and D. Parekh (2020). COVID-19 and the liver: Little cause for concern. The Lancet: Gastroenterology & Hepatology, 5(6): 529.
Chau, T.N., Lee, K.C., Yao, H., Tsang, T.Y., Chow, T.C., Yeung, Y.C. and S.T. Lai (2004). SARS‐associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology, 39(2): 302-310.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y. and Y. Wei (2020). Epidemiological & clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223): 507-513.
Chen, W., Zheng, K.I., Liu, S., Yan, Z., Xu, C. and Z. Qiao (2020). Plasma CRP level is positively associated with the severity of COVID-19. Annals of Clinical Microbiology and Antimicrobials, 19(1): 1-7.
Colafrancesco, S., Alessandri, C., Conti, F. and R. Priori (2020). COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Autoimmunity Reviews, 19(7): 102573.
Drakesmith, H. and A. Prentice (2008). Viral infection and iron metabolism. Nature Reviews Microbiology, 6(7): 541-552.
Essa, R.A., Ahmed, S.K., Bapir, D.H. and C.P. Abubakr (2021). Hyperbilirubinemia with mild COVID-19 patient: A case report. International Journal of Surgery Case Reports, 82: 105958.
Faiq, T.N., Ghareeb, O.A. and M.F. Fadhel (2021). Characteristics and outcomes of COVID 19 patients in Kirkuk City, Iraq. Annals of the Romanian Society for Cell Biology, 25(4): 12432-12438.
Fan, Z., Chen, L., Li, J., Cheng, X., Yang, J., Tian, C. and J. Cheng (2020). Clinical features of COVID-19-related liver functional abnormality. Clinical Gastroenterology and Hepatology, 18(7): 1561-1566.
Fu, J., Kong, J., Wang, W., Wu, M., Yao, L., Wang, Z., and X. Yu. (2020). The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thrombosis Research, 192: 3-8.
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H.K., Morgan, R. and S.L. Klein (2020). Impact of sex and gender on COVID-19 outcomes in Europe. Biology of Sex Differences, 11: 1-13.
Gemmati, D., Bramanti, B., Serino, M.L., Secchiero, P., Zauli, G. and V. Tisato (2020). COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females be protective against SARSCoV-2 compared to the single X-chromosome in males? International Journal of Molecular Sciences, 21(10): 3474.
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A. and E. Zoia (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA, 323(16): 1574-1581.
Harmer, D., Gilbert, M., Borman, R. and K.L. Clark (2002). Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Letters, 532(1-2): 107-110.
Herold, T., Jurinovic, V., Arnreich, C., Lipworth, B.J., Hellmuth, J.C., von Bergwelt-Baildon, M. and T.Weinberger (2020). Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. Journal of Allergy and Clinical Immunology, 146(1): 128-136.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y. and X. Gu (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223): 497-506.
Huang, I., Pranata, R., Lim, M.A., Oehadian, A. and B. Alisjahbana (2020). C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: A meta-analysis. Therapeutic Advances in Respiratory Disease, 14: 1753466620937175.
Hussein, A.M., Taha, Z.B., Malek, A.G., Rasul, K.A., Hazim, D.Q., Ahmed, R.J. and U.B. Mohamed (2021). D-dimer and serum ferritin as an independent risk factor for severity in COVID-19 patients. Materials Today: Proceedings (In Press).
Hwaiz, R., Merza, M., Hamad, B., HamaSalih, S., Mohammed, M. and H. Hama (2021). Evaluation of hepatic enzymes activities in COVID-19 patients. International Immunopharmacology, 97: 107701.
Jakhmola, S., Baral, B. and H.C. Jha (2021). A comparative analysis of COVID-19 outbreak on age groups and both the sexes of population from India and other countries. The Journal of Infection in Developing Countries, 15(03): 333-341.
Kaushal, K., Kaur, H., Sarma, P., Bhattacharyya, A., Sharma, D.J., Prajapat, M., Pathak, M., Kothari, A., Kumar, S., Rana, S., Kaur, M., Prakash, A., Mirza, A.A., Panda, P.K., Vivekanandan, S., Omar, B.J., Medhi, B. and M. Naithani (2022). Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis, and meta-regression analysis. Journal of Critical Care, 67: 172-181.
Koozi, H., Lengquist, M. and A. Frigyesi (2020). C-reactive protein as a prognostic factor in intensive care admissions for sepsis: A Swedish multicenter study. Journal of Critical Care, 56: 73-79.
Li, H., Xiang, X., Ren, H., Xu, L., Zhao, L., Chen, X. and Q. Wu (2020). SAA is a biomarker to distinguish the severity and prognosis of coronavirus disease 2019 (COVID-19). The Journal of Infection, 80(6): 646-655.
Lin, L., Lu, L., Cao, W. and T. Li (2020). Hypothesis for potential pathogenesis of SARS-CoV-2 infection–A review of immune changes in patients with viral pneumonia. Emerging Microbes & Infections, 9(1): 727-732.
Marabotto, E., Ziola, S. and E. Giannini (2020). COVID-19 and liver disease: Not all evil comes to harm. Liver International, 41(1): 237-238.
Mizumoto, K., Kagaya, K., Zarebski, A. and G. Chowell (2020). Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance, 25(10): 2000180.
Nardo, A.D., Schneeweiss‐Gleixner, M., Bakail, M., Dixon, E.D., Lax, S.F. and M. Trauner (2021). Pathophysiological mechanisms of liver injury in COVID‐19. Liver International, 41(1): 20-32.
Piano, S., Dalbeni, A., Vettore, E., Benfaremo, D., Mattioli, M., Gambino, C.G. and COVID‐LIVER study group (2020). Abnormal liver function tests predict transfer to intensive care unit and death in COVID‐19. Liver International, 40(10): 2394-2406.
Pirola, C.J. and S. Sookoian (2020). COVID-19 and ACE2 in the liver and gastrointestinal tract: Putative biological explanations of sexual dimorphism. Gastroenterology, 159(4): 1620.
Pringle, K., Tadros, M., Callister, R. and E. Lumbers (2011). The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: Roles in trophoblast invasion and angiogenesis? Placenta, 32(12): 956-962.
Robert Koch Institute (2020). Coronavirus disease 2019 (COVID-19): Daily situation report of the Robert Koch Institute.
Saber-Ayad, M., Saleh, M.A. and E. Abu-Gharbieh (2020). The rationale for potential pharmacotherapy of COVID-19. Pharmaceuticals, 13(5): 96.
Siddiqi, H.K. and M.R. Mehra (2020). COVID-19 illness in native and immunosuppressed states: A clinical– therapeutic staging proposal. The Journal of Heart and Lung Transplantation, 39(5): 405.
Sohrabi, C., Alsafi, Z., O’neill, N., Khan, M., Kerwan, A., AlJabir, A., and R. Agha (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76: 71-76.
Soltani, S., Zakeri, A.M., Karimi, M.R., Rezayat, S.A., Anbaji, F.Z., Tabibzadeh, A. and M. Norouzi (2020). A systematic literature review of current therapeutic approaches for COVID-19 patients. J. Pharm. Res. Int., 32(7): 13-25.
Sproston, N.R. and J.J. Ashworth (2018). Role of C-reactive protein at sites of inflammation and infection. Frontiers in Immunology, 9: 754.
Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M. and F. Sampaziotis (2020). SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nature Medicine, 2: 681-687.
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M. and T. Iba (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. Journal of Thrombosis and Haemostasis, 18(5): 1023-1026
Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z. and S. Zhang (2020). The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The perspectives of clinical immunologists from China. Clinical Immunology, 214: 108393.